Rezultati - Daniel Breadner
- Showing 1 - 4 results of 4
-
1
-
2
Efficacy and safety of camrelizumab combined with chemotherapy in the first-line treatment of advanced gastric cancer: a single-arm, phase II study od Wenlou Liu, Hongmei Wang, Yang Zhao, Yan Ge, Juangjuang Tang, Menghan Cao, Silvio Matsas, Daniel Breadner, Xiaobing Qin, Zhengxiang Han
Izdano 2024Artigo -
3
-
4
Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma od Tuo Zhang, Beibei Sun, Chenxi Zhong, Ke Xu, Zhexin Wang, Paul Hofman, Tatsuya Nagano, Antoine Legras, Daniel Breadner, Biagio Ricciuti, Duilio Divisi, Ralph A. Schmid, Ren‐Wang Peng, Haitang Yang, Feng Yao
Izdano 2021Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Oncology
Cancer
Cancer research
Chemotherapy
Lung cancer
Biochemistry
Biology
Carcinoma
Clinical trial
Disease
Epidermal growth factor receptor
First line
Gene
Histone
Histone deacetylase
Immunotherapy
Papillary carcinoma
Papillary thyroid cancer
Pathology
Presentation (obstetrics)
Radiology
Retrospective cohort study
Targeted therapy
Thyroid
Thyroid cancer
Thyroid carcinoma
Vorinostat